Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CLPTNASDAQ:MGRMNASDAQ:NPCENASDAQ:SMLR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCLPTClearPoint Neuro$11.25+0.7%$12.80$5.11▼$19.22$314.88M0.93245,291 shs187,370 shsMGRMMonogram Orthopaedics$2.93+1.7%$2.69$1.92▼$4.21$104.57M0.41248,730 shs102,386 shsNPCENeuroPace$10.60-1.7%$12.83$5.45▼$18.98$347.67M2.03171,285 shs237,824 shsSMLRSemler Scientific$31.94+12.0%$35.32$21.77▼$81.56$356.18M1.42517,004 shs1.56 million shs10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCLPTClearPoint Neuro+0.72%-12.45%-14.25%-17.70%+114.29%MGRMMonogram Orthopaedics+1.74%+10.98%+8.92%-6.09%+39.52%NPCENeuroPace-1.67%-10.40%-37.65%-8.93%+63.08%SMLRSemler Scientific+11.95%+0.69%-26.18%-17.72%-14.26%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCLPTClearPoint Neuro2.7453 of 5 stars3.54.00.00.02.40.80.6MGRMMonogram Orthopaedics2.2386 of 5 stars3.83.00.00.00.01.70.6NPCENeuroPace3.7407 of 5 stars3.45.00.00.02.44.20.6SMLRSemler Scientific1.9251 of 5 stars3.52.00.00.01.12.50.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCLPTClearPoint Neuro 3.00Buy$25.00122.22% UpsideMGRMMonogram Orthopaedics 3.50Strong Buy$5.4084.30% UpsideNPCENeuroPace 2.83Moderate Buy$15.5046.23% UpsideSMLRSemler Scientific 3.00Buy$71.00122.29% UpsideCurrent Analyst Ratings BreakdownLatest MGRM, NPCE, SMLR, and CLPT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/28/2025NPCENeuroPaceHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$18.005/14/2025NPCENeuroPaceJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$14.00 ➝ $16.005/14/2025NPCENeuroPaceCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$17.00 ➝ $17.004/1/2025CLPTClearPoint NeuroStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$19.00 ➝ $25.00(Data available from 6/19/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCLPTClearPoint Neuro$31.39M10.03N/AN/A$0.92 per share12.23MGRMMonogram Orthopaedics$370K282.63N/AN/A$0.42 per share6.98NPCENeuroPace$84.31M4.12N/AN/A$0.27 per share39.26SMLRSemler Scientific$56.29M6.33$4.47 per share7.14$24.90 per share1.28Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCLPTClearPoint Neuro-$18.91M-$0.76N/AN/AN/A-64.51%-78.09%-51.33%8/6/2025 (Estimated)MGRMMonogram Orthopaedics-$16.33M-$0.45N/AN/AN/AN/A-115.71%-92.75%8/13/2025 (Estimated)NPCENeuroPace-$27.14M-$0.84N/AN/AN/A-29.42%-190.84%-25.08%8/12/2025 (Estimated)SMLRSemler Scientific$40.90M-$2.61N/A∞N/A-60.69%19.75%15.47%8/4/2025 (Estimated)Latest MGRM, NPCE, SMLR, and CLPT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025MGRMMonogram Orthopaedics-$0.12-$0.10+$0.02-$0.10N/AN/A5/13/2025Q1 2025CLPTClearPoint Neuro-$0.15-$0.22-$0.07-$0.22$8.21 million$8.49 million5/13/2025Q1 2025NPCENeuroPace-$0.26-$0.21+$0.05-$0.21$21.85 million$22.52 million5/13/2025Q1 2025SMLRSemler ScientificN/A-$0.76N/A-$6.74N/A$8.84 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCLPTClearPoint NeuroN/AN/AN/AN/AN/AMGRMMonogram OrthopaedicsN/AN/AN/AN/AN/ANPCENeuroPaceN/AN/AN/AN/AN/ASMLRSemler ScientificN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCLPTClearPoint NeuroN/A3.532.57MGRMMonogram OrthopaedicsN/A7.007.00NPCENeuroPace2.466.635.70SMLRSemler Scientific0.590.520.51Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCLPTClearPoint Neuro30.08%MGRMMonogram Orthopaedics0.45%NPCENeuroPace78.83%SMLRSemler Scientific49.37%Insider OwnershipCompanyInsider OwnershipCLPTClearPoint Neuro6.97%MGRMMonogram Orthopaedics28.10%NPCENeuroPace20.50%SMLRSemler Scientific30.20%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCLPTClearPoint Neuro11027.99 million26.04 millionOptionableMGRMMonogram Orthopaedics2835.69 million25.66 millionNot OptionableNPCENeuroPace17032.80 million26.08 millionOptionableSMLRSemler Scientific12011.15 million7.78 millionNot OptionableMGRM, NPCE, SMLR, and CLPT HeadlinesRecent News About These CompaniesSemler Scientific® Appoints Joe Burnett as Director of Bitcoin Strategy; Targets Owning at Least 10,000 Bitcoins by Year-End 2025 and 105,000 by Year-End 2027June 19 at 4:45 PM | prnewswire.comSMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About Your RightsJune 19 at 4:33 PM | globenewswire.comRosen Law Firm Encourages Semler Scientific, Inc. Investors to Inquire About Securities Class Action Investigation - SMLRJune 17 at 3:15 PM | prnewswire.comVanEck’s Sigel warns Bitcoin treasury companies as Semler Scientific approaches danger zoneJune 17 at 11:58 AM | msn.comWolf Haldenstein Adler Freeman & Herz LLP is investigating Semler Scientific Inc.June 17 at 8:24 AM | globenewswire.comSMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About Your RightsJune 16 at 8:14 PM | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Semler Scientific Inc. - SMLRJune 16 at 3:02 PM | accessnewswire.comBitcoin Accumulation Strategy Under Threat As Stock Prices Plummet, Says VanEckJune 16 at 7:25 AM | coingape.comBank of America Corp DE Trims Position in Semler Scientific, Inc. (NASDAQ:SMLR)June 14, 2025 | marketbeat.comSMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About Your RightsJune 13, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Semler Scientific Inc. - SMLRJune 13, 2025 | accessnewswire.comBronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Semler Scientific, Inc. (SMLR) And Encourages Shareholders to Reach OutJune 12, 2025 | accessnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Semler Scientific Inc. - SMLRJune 12, 2025 | prnewswire.comROSEN, A TOP-RANKED FIRM, Encourages Semler Scientific, Inc. Investors to Inquire About Securities Class Action Investigation - SMLRJune 11, 2025 | accessnewswire.comTom Lee Mulls Roughed-Up Semler Scientific for 'Granny Shot' PortfolioJune 11, 2025 | coindesk.comBronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Semler Scientific, Inc. (SMLR) and Encourages Shareholders to Learn More About the InvestigationJune 11, 2025 | accessnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Semler Scientific Inc. - SMLRJune 11, 2025 | accessnewswire.comRosen Law Firm Encourages Semler Scientific, Inc. Investors to Inquire About Securities Class Action Investigation - SMLRJune 10, 2025 | prnewswire.comTraders Purchase Large Volume of Semler Scientific Call Options (NASDAQ:SMLR)June 10, 2025 | marketbeat.comSemler Scientific, Inc. (SMLR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the InvestigationJune 10, 2025 | accessnewswire.comSMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. ...June 9, 2025 | gurufocus.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMGRM, NPCE, SMLR, and CLPT Company DescriptionsClearPoint Neuro NASDAQ:CLPT$11.25 +0.08 (+0.72%) Closing price 06/18/2025 04:00 PM EasternExtended Trading$11.20 -0.05 (-0.44%) As of 06/18/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.Monogram Orthopaedics NASDAQ:MGRM$2.93 +0.05 (+1.74%) Closing price 06/18/2025 04:00 PM EasternExtended Trading$2.97 +0.04 (+1.37%) As of 06/18/2025 06:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was founded in 2015 and is headquartered in Austin, Texas.NeuroPace NASDAQ:NPCE$10.60 -0.18 (-1.67%) Closing price 06/18/2025 04:00 PM EasternExtended Trading$10.61 +0.01 (+0.09%) As of 06/18/2025 07:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.Semler Scientific NASDAQ:SMLR$31.94 +3.41 (+11.95%) Closing price 06/18/2025 04:00 PM EasternExtended Trading$31.94 0.00 (0.00%) As of 06/18/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Robinhood Director Sells Millions, But HOOD Stock Eyes Gains Coinbase Stock Pops as Senate Passes GENIUS Stablecoin Bill Chime’s Smart IPO: Half the Valuation, Double the Strength 3 Tech Stocks With High and Rising Institutional Interest Salesforce Raises Prices: 3 Reasons Its Stock Price Will Follow Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
